Metabolic and Bariatric Surgery · 17 April 2024

Gastrin Orchestrates Glucose Regulation Post-Sleeve Gastrectomy

Gastrin plays a central role in glucose improvement after sleeve gastrectomy (SG). SG induces a medium-term elevation of the insulin response and plasma gastrin levels, with long-term depletion of the insulin response and elevated oral glucose tolerance test results. Gastrin antagonists, like netazepide, prevent these effects. This study highlights the dual effects of gastrin on insulin release and beta-cell mass post-SG.

Journal Article by Pérez-Arana GM, Almorza-Gomar D (…) Prada-Oliveira JA et 7 al. in J Gastrointest Surg

read the whole article in J Gastrointest Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →